NCT03217981 (HUVR) is a clinical trial of Sepsis protocol in Sepsis, sponsored by Unimed Volta Redonda.

Who is sponsoring NCT03217981?

NCT03217981 is sponsored by Unimed Volta Redonda.

What drugs are being tested in NCT03217981?

Interventions in NCT03217981: Sepsis protocol.

Is NCT03217981 still recruiting?

NCT03217981 is currently status unknown. Last updated 4 August 2017.

Last reviewed 2017-08-04 · How we verify

NCT03217981: HUVR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sepse: Critical Analysis of New Sepse Definitions and Retrospective Evaluation of Sepse Protocol at a Tertiary Hospital in Brazil

Status unknown Last updated 4 August 2017

What this trial tests

trial testing Sepsis protocol in Sepsis in 506 participants. Status unknown.

Timeline

2 August 2017

Primary endpoint
5 August 2017

8 August 2017

Quick facts

Lead sponsor	Unimed Volta Redonda
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	506
Start date	2 August 2017
Primary completion	5 August 2017
Estimated completion	8 August 2017
Sites	1 location across Brazil

Drugs / interventions tested

Sepsis protocol

Conditions studied

Sepsis — all drugs for Sepsis →

Sponsor

Unimed Volta Redonda

Who can join

18 and older, any sex, with Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Research in the databases Lilacs, BIREME, SciELO by the terms: systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis and septic shock and their equivalents in the English language. Selection of the main articles of the last five years to study and contextualize the reality presented since the implantation of the HUVR sepsis protocol. Statistical analysis of data since the implementation of the sepsis protocol in the HUVR, in July 2014 until June 2016.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sepsis

Currently open trials in the same condition.

NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03217981 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Unimed Volta Redonda
Last refreshed: 4 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03217981.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing